NMS-03597812

N/A

Report date: 2024/07/10 11:08:16

NME

Base Information

Drug NameNMS-03597812

Drug Alias NameNMS-03597812NMS-812

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEukaryotic Translation Initiation Factor 2 Alpha Kinase 3 inhibitorsEukaryotic translation initiation factor 2-alpha kinase 4 inhibitors

TargetsEukaryotic Translation Initiation Factor 2 Alpha Kinase 3Eukaryotic translation initiation factor 2-alpha kinase 4

Therapy Area/IndicationsMultiple MyelomaLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNerviano Medical Sciences Srl

China Registration ClassN/A

Develop Information

Active CompaniesNerviano Medical Sciences Srl

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A